Company Analysis

Minerva Neurosciences, Inc (NERV)

Nasdaq: NERV · Pharmaceutical Preparations · Burlington, MA · filing with the SEC since 2014
Grade6.0
◀ Past 6.3● Present 5.1▶ Future 6.7
4 est.

Who runs Minerva Neurosciences, Inc

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Luthringer Remy
CEO. First filing Jun 2014, latest Jun 5, 2026, 6 filings in all.
Officers reporting now
6
of 11 people with a filing in the last fifteen months
Directors reporting now
5
22 people on the record since 2014
Officerssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Reilly Joseph H.Chief Operating OfficerJun 2014Aug 20, 2026none
Aliquo AnthonyChief Accounting OfficerAug 2026Aug 20, 2026none
Luthringer RemyCEOJun 2014Jun 5, 2026none
Ahlholm Frederick WSVP, CFO and SecretaryJun 2014Jun 5, 2026none
O'Connor James JosephChief Business Officer and GCApr 2026Apr 22, 2026none
Race GeoffPresidentJun 2014Dec 23, 2025none
Directorssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameRoleFirst filingLatest filingSales, 12 months
Kaul InderjitdirectorNov 2025Nov 3, 2026none
Hasler Hans PeterdirectorDec 2017Jun 5, 2026none
Kupfer DaviddirectorNov 2015Jun 5, 2026none
Laghrissi-Thode FouziadirectorMay 2015Jun 5, 2026none
Van Heek G JandirectorJun 2014Jun 5, 2026none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton NERV · research, not advice